Health Care & Life Sciences » Biotechnology | Medpace Holdings Inc.

Medpace Holdings Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
24,844.00
15,572.00
8,673.00
13,425.00
39,122.00
73,185
Depreciation, Depletion & Amortization
30,519.00
68,063.00
69,521.00
58,114.00
46,474.00
38,801
Other Funds
16.00
6,079.00
-
523.00
-
1,055
Funds from Operations
69,203.00
57,486.00
82,240.00
84,631.00
84,504.00
116,983
Changes in Working Capital
28,501.00
17,716.00
3,630.00
7,101.00
12,881.00
39,601
Net Operating Cash Flow
97,704.00
75,202.00
85,870.00
91,732.00
97,385.00
156,584
Capital Expenditures
4,561.00
5,315.00
6,465.00
13,537.00
12,293.00
Net Investing Cash Flow
4,472.00
908,467.00
6,432.00
13,422.00
12,237.00
Issuance/Reduction of Debt, Net
97,496.00
462,124.00
117,347.00
228,881.00
55,943.00
Net Financing Cash Flow
95,851.00
882,203.00
116,489.00
58,008.00
97,828.00
Net Change in Cash
2,460.00
48,128.00
37,652.00
19,670.00
10,915.00
Free Cash Flow
93,143.00
69,887.00
79,405.00
78,195.00
85,661.00
Deferred Taxes & Investment Tax Credit
5,982.00
9,257.00
12,690.00
9,006.00
3,237.00
3,942
Net Assets from Acquisitions
-
903,453.00
-
-
-
Other Sources
89.00
301.00
33.00
115.00
56.00
Change in Capital Stock
1,629.00
414,000.00
858.00
171,396.00
153,771.00
Exchange Rate Effect
159.00
810.00
601.00
632.00
1,765.00

About Medpace Holdings

View Profile
Address
5375 Medpace Way
Cincinnati Ohio 45227
United States
Employees -
Website http://www.medpace.com
Updated 07/08/2019
Medpace Holdings, Inc. engages in the research, development, and trading of medical device and pharmaceutical products. Its services include medical affairs, clinical trial management, study feasibility, study-start-up, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August J.